Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02622542 · ClinicalTrials.gov registry record · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
A NA study of Distal Aortic Dissection and Dissection, Aortic Acute, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 436
- Enrollment target
- 2
- Study locations
NCT02622542: Recruiting NA study of Distal Aortic Dissection and Dissection, Aortic Acute, sponsored by The University of Texas Health Science Center, Houston.
NCT02622542 is a NA study of Distal Aortic Dissection and Dissection, Aortic Acute that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 436 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02622542, a NA study of Distal Aortic Dissection and Dissection, Aortic Acute, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 436 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to conduct a randomized controlled trial comparing best medical therapy (BMT) alone to BMT with thoracic endovascular aortic repair (BMT+TEVAR) for uncomplicated acute type B aortic dissection.
Conditions Studied
Interventions
- DEVICE BMT+TEVAR
- OTHER BMT
Study Locations (2)
Texas
- Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center - Houston
- Department of Cardiothoracic and Vascular Surgery; Memorial Hermann Hospital Southeast - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 436 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT02622542 shows while recruiting
NCT02622542 is an interventional study that assigns participants to a tested intervention. The registered 436 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 3 conditions, with Distal Aortic Dissection appearing as the primary indexed condition, and to 2 interventions - of which BMT+TEVAR is the first listed.
NCT02622542 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02622542 about?
NCT02622542 is a clinical study titled "ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy". The purpose of the study is to conduct a randomized controlled trial comparing best medical therapy (BMT) alone to BMT with thoracic endovascular aortic repair (BMT+TEVAR) for uncomplicated acute type B aortic dissection.
What is the current status of trial NCT02622542?
This trial is currently recruiting. It is a NA study. The enrollment target is 436 participants. The study started on 2018-10-01. Estimated completion is 2026-06.
What conditions does trial NCT02622542 study?
This clinical trial studies the following conditions: Distal Aortic Dissection, Dissection, Aortic Acute, Acute Type B Aortic Dissection (Uncomplicated).
What interventions are being tested in trial NCT02622542?
The interventions under investigation include: BMT+TEVAR (DEVICE), BMT (OTHER).
Who is sponsoring clinical trial NCT02622542?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02622542 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02622542's enrollment target sits among peer trials
436 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
- NCT06966479 · 436 participants · Phase 2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
- NCT07318493 · 436 participants · NA
Antiseptic-Coated Sutures and Pancreatic Fistula Risk After Pancreatoduodenectomy
- NCT05563220 · 435 participants · Phase 1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI